Latest News

Common multiple sclerosis drugs taken together do not reduce relapse risk

A recent clinical trial found that interferonβ-1a (INF) and glatiramer acetate (GA), two of the most commonly prescribed drugs for multiple sclerosis (MS), provide no additional clinical benefit when taken together. While findings suggest that taking both INF and GA together was not superior to GA monotherapy in reducing relapse risk; the combination therapy does appear to reduce new lesion activity and total lesion volume.
View full story

Post your comment.

Name:
Email:
Rating:
Comment:
Verification
 

  • Neural compensation in people with Alzheimer's-related protein

  • Measuring modified protein structures: New approach

  • Identifying a better message strategy for dissuading smokers: Add the positive

  • Concept of time may predict impulsive behavior, research finds

  • Web based training can reduce campus rape, study concludes

  • Exxon Valdez 2014: Does media coverage of humanmade disasters contribute to consumer complacency?

  • We see art more as a person than an object: 'Magical contagion' spreads creator's essence to pieces

  • Do ads showing sexy women make male consumers less charitable?

  • Do you always get what you pay for? How consumers mispredict product quality

  • Why are consumers willing to spend more money on ethical products?

  •